![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas : A Prospective Multicenter Study of Korean Patients |
Jin-Deok Joo, Jong Hee Chang, Jeong Hoon Kim, Yong-Kil Hong, Young-Hoon Kim, Chae-Yong Kim |
Journal of Korean Neurosurgical Society. 2012;52(2):92-97. Published online 2012 August 31 DOI: https://doi.org/10.3340/jkns.2012.52.2.92 |
Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas : A Prospective Multicenter Study of Korean Patients Validation of the Effectiveness and Safety of Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas: 10-year Experience of a Single Institution Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma 198 oral Acute toxicity of an adjuvant radiochemotherapy (RCT) with temozolomide (TMZ) in patients with newly diagnosed primary high grade brain tumors A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly population 988 poster TO INVESTIGATE WHETHER THERE IS EVIDENCE OF A CORRELATION BETWEEN THE PLANNING TARGET VOLUME (PTV) AND THROMBOCYTOPENIA DURING CONCOMITANT TREATMENT WITH RADIATION AND DAILY TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GBM ATIM-46. A MULTICENTER, PHASE I, TRIAL OF RADIATION, TEMOZOLOMIDE AND RRx-001 FOLLOWED BY MAINTENANCE TEMOZOLOMIDE WITH OR WITHOUT RRx-001 IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas |
This metadata service is kindly provided by CrossRef from May 29, 2014. J Korean Neurosurg Soc has participated in CrossRef Text and Data Mining service since March 1, 2015. |